Wnt/beta-catenin signaling pathway as a novel cancer drug target.
Luu HH, Zhang R, Haydon RC, Rayburn E, Kang Q, Si W, Park JK, Wang H, Peng Y, Jiang W, He TC.
Luu HH, et al. Among authors: he tc.
Curr Cancer Drug Targets. 2004 Dec;4(8):653-71. doi: 10.2174/1568009043332709.
Curr Cancer Drug Targets. 2004.
PMID: 15578921
Review.